Donate
About Us
Our Vision, Mission & Values
About Clyde Campbell
Our MJFF partnership
Our Board
Our Team
Our Ambassadors
Annual Report
Research
Our MJFF Partnership
Our Research Projects
The Shake It Up Australia Movement Disorder Capacity Building Program
Australian Parkinson’s Genetics Study (Now Recruiting)
Catalyst Programme velocity (CPv)
Research Trials
How We Fund Parkinson’s Research
News
About PD
Symptoms of Parkinson’s
Treatments for Parkinson’s
Living with Parkinson’s
Sharing Your Diagnosis
Young Onset Parkinson’s
Genetics
Caregiver Information
Parkinson’s Stories
Trials
Podcast
Contact
Get Involved
Fundraise for Parkinson’s
In Memory Donations
Bequest to Parkinson’s
Corporate Support
Donate
About Us
Our Vision, Mission & Values
About Clyde Campbell
Our MJFF partnership
Our Board
Our Team
Our Ambassadors
Annual Report
Research
Our MJFF Partnership
Our Research Projects
The Shake It Up Australia Movement Disorder Capacity Building Program
Australian Parkinson’s Genetics Study (Now Recruiting)
Catalyst Programme velocity (CPv)
Research Trials
How We Fund Parkinson’s Research
News
About PD
Symptoms of Parkinson’s
Treatments for Parkinson’s
Living with Parkinson’s
Sharing Your Diagnosis
Young Onset Parkinson’s
Genetics
Caregiver Information
Parkinson’s Stories
Trials
Podcast
Contact
Get Involved
Fundraise for Parkinson’s
In Memory Donations
Bequest to Parkinson’s
Corporate Support
Donate
Tag:
Research Trial
The Michael J. Fox Foundation for Parkinson’s Research Finds Parkinson’s Biomarker
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announced an enormous leap forward in the understanding of Parkinson’s disease w...
Taking Steps Against Parkinson’s Disease – A New Research Project
Parkinson’s disease (PD) currently affects over 10 million people worldwide, and 200,000 Australians live with the disease, while another 38 are...
Abbvie Research Study to Understand the Impact of Parkinson’s
A new research study being conducted by Abbvie aims to understand how Parkinson’s disease is affecting people living with the condition, their f...
TONiC Research Study Aims to Improve Care for Patients
Parkinson’s disease (PD) isn’t the same for every patient. Patients will progress at different rates, or experience certain symptoms that affect t...
Alzheimer’s Drug Approval Shows Power of Protein Markers as Parkinson’s Field Seeks Same
The U.S. Food and Drug Administration (FDA) last week approved lecanemab (brand name Leqembi) developed by Eisai Co Ltd. and Biogen Inc. for people w...
David Cox trials Walking Tall’s Device on Bondi to Manly Walk
Congratulations to David and his team for walking over 42kms in 10 hours to raise awareness and over $6700 for Parkinson’s research. David is an...
×